Medication info
Almix Tablet (Memantine Hydrochloride)

Almix Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Penmix Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002024 · Approved 2020.03.23

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily, at the same time each day. If necessary, this drug may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, reach the maintenance dose by increasing the dose by 5mg per week over the first 3 weeks as follows. Week 1 (days 1~7): Administer 5mg daily for 7 days. Week 2 (days 8~14): Administer 10mg daily for 7 days. Week 3 (days 15~21): Administer 15mg daily for 7 days. From week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Penmix Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used to treat moderate to severe Alzheimer's disease.

How to take

Adult dose

This drug is administered orally once daily, at the same time each day. If necessary, this drug may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, reach the maintenance dose by increasing the dose by 5mg per week over the first 3 weeks as follows. Week 1 (days 1~7): Administer 5mg daily for 7 days. Week 2 (days 8~14): Administer 10mg daily for 7 days. Week 3 (days 15~21): Administer 15mg daily for 7 days. From week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This drug should not be used in patients with hypersensitivity to any component or severe liver or kidney dysfunction. Patients with epilepsy or a history of seizures should use this medication with caution, and must consult a physician as adverse effects may be exacerbated when combined with certain drugs. Use of this drug may cause side effects such as dizziness, headaches, constipation, drowsiness, and hypertension, and if symptoms worsen, medical attention should be sought immediately. There may be interactions with other medications, so it is essential to inform your doctor or pharmacist, especially if you are taking NMDA antagonists, antipsychotics, or muscle relaxants. Women who are pregnant or breastfeeding must consult a doctor before using this medication, and it is recommended to discontinue breastfeeding during the treatment. The safety and efficacy of this drug in children and adolescents under 18 years have not been established, so its use is not recommended. In case of overdose, serious central nervous system symptoms such as coma, hallucinations, and seizures can occur, so it is crucial to adhere to the prescribed dosage and seek immediate medical care if an overdose occurs. This medication may affect reaction times, increasing the risk of accidents while driving or operating machinery, so caution is advised during such activities. Keep out of reach of children and do not transfer to other containers as it is important for maintaining the quality of the medication.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 32 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • shortness of breath
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disorder
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture, and keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.